Skip to main content
OpenTrials
Completed

NCT Number: NCT02682004

Serotonin, Leptin and Adiponectin Level in Patients With Postpartum Depression: Controlled Study

After vaginal delivery, all of the participants will evaluate by using Edinburg depression scale and venous blood sample will obtain. Postpartum depression will consider the result of scale 13 and above according to Turkhish translate. Then leptin, adiponectin and serotonin level will compare between depressed and nondepressed women.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–40 year

Sex eligibility

Female

Study type

Observational

Primary location

Zeynep Kamil Maternity and Pediatric Research and Training Hospital

Istanbul, 34668, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All women who gave birth

Exclusion criteria

  • women with previously diagnosed depression and any psychiatric disorders
  • women with previously take antidepressan and antipshycothic
  • women giving birth to children with anomalies
  • women with undertake surgery for peripartum hemorrhage

Treatment and study plan

leptin, serotonin and adiponectin level

Other

leptin,serotonin, adiponectin level

Other

Primary outcomes

  1. Blood level (ng/ml) ELİSA

    Time frame: 1 month

Sponsors and collaborators

Lead sponsor

Zeynep Kamil Maternity and Pediatric Research and Training Hospital

Other

Registry information

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Feb 15, 2016
Registry last updated
Mar 15, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.